News

San Diego Blood Bank (SDBB) is launching a program to enable community volunteers to participate in genomics research

In a first-of-its-kind pilot, the San Diego Blood Bank (SDBB) is launching a program to enable community volunteers to participate in genomics research.  The objective of the pilot program is to develop a model for population-scale research that is truly participant-centric and cultivates long-term participant engagement for maximum diversity and research

Read More »

Indiana Blood Center CEO Announcement to Industry

Charlie Miraglia, M.D. Announced as New CEO of Indiana Blood Center Prominent healthcare executive set to become new leader for non-profit’s new era Indianapolis, Ind. (October 12, 2015) – Charles C. Miraglia, M.D., a prominent healthcare executive, has been named the new president and CEO of Indiana Blood Center, a

Read More »

BBD Produces INTERCEPT Pathogen Reduced Platelet Units

FOR IMMEDIATE RELEASE: CONTACT: Joseph Yelo, MBA, MT (ASCP) SBB Thursday, August 20, 2015 Lead Executive, Business & Community Development 302-737-8405 ext. 866 jyelo@bbd.org BBD Produces INTERCEPT Pathogen Reduced Platelet Units Newark, DE – The Blood Bank of Delmarva (BBD) announced today the production of pathogen reduced platelets. BBD was

Read More »

Rob Van Tuyle Appointed New Chief Executive Officer of BloodSource

Sacramento, CA – BloodSource today announced that its Board of Directors has appointed Rob Van Tuyle as Chief Executive Officer (CEO), succeeding former CEO Mike Fuller who recently retired.   “Rob is a highly respected leader in the national and global blood banking community through his involvement with various industry

Read More »

BloodCenter of Wisconsin launches gene deletion/duplication analysis

Approach provides comprehensive genetic diagnosis for patients with rare genetic bleeding disorders MILWAUKEE, July 13, 2015 /PRNewswire-USNewswire/ — BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti™, today announced the availability of genetic deletion/duplication analysis. Using array Comparative Genomic Hybridization (aCGH), this test provides timely detection of deletions and/or duplications which

Read More »

New COO Named at Michigan Blood

GRAND RAPIDS, Mich. (June 15, 2015) – Jim Wilson has been appointed Chief Operating Officer (COO) for Michigan Blood.  As COO, Wilson will be responsible for leadership of all aspects of operations including blood collection, donor safety and specialty testing, component preparation, product inventory management, order fulfillment and distribution, facilities

Read More »